Encoded Therapeutics has linked its Dravet syndrome gene therapy ETX101 to a 78% reduction in seizures, keeping the biotech on track to start a pivotal study next year. The Californian company’s ...

SOUTH SAN FRANCISCO, Calif., December 05, 2025--(BUSINESS WIRE)--Encoded Therapeutics Inc., a clinical-stage biotechnology company developing genetic medicines for severe neurological disorders, today ...

– Oral and poster presentations to include seizure and neurodevelopmental data from POLARIS Phase 1/2 Program that support advancement of ETX101 – SOUTH SAN FRANCISCO, Calif., December 01, ...

We independently review everything we recommend. When you buy through our links, we may earn a commission. Learn more› By Adrienne Maxwell Adrienne Maxwell is an editor covering AV gear. Her specialty ...

On October 13, a group of Indigenous artists took over the American collection at New York’s Metropolitan Museum of Art to emphasize the need to elevate alternative narratives on Columbus Day—now ...

Oct 8 (Reuters) - Base Power said on Wednesday that it had raised $1 billion in its latest funding round, as it looks to ramp up its business of leasing batteries to homeowners to meet rising power ...

Support multiple variants alphabet and padding: It is possible to use this module in other methods/ways which not listed in here, however those methods/ways are not officially supported, and should ...

DNA-encoded libraries have numerous advantages over traditional screening methods, including easy identification of compounds and the large quantity of compounds that can be screened simultaneously.

Encoded Therapeutics is shrinking its headcount by 29% as the gene therapy biotech draws resources away from its early-stage R&D toward its Dravet syndrome program. The asset in question, dubbed ...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Encoded Therapeutics Inc., a clinical-stage biotechnology company developing genetic medicines for severe central nervous system (CNS) disorders, today ...